Yu Fan is an investment fund managing more than $76.5 billion ran by Fan Yu. There are currently 6 companies in Yu’s portfolio. The largest investments include Cg Oncology Inc and Cargo Therapeutics Inc, together worth $64.8 billion.
As of 7th August 2024, Yu Fan’s top holding is 1,578,344 shares of Cg Oncology Inc currently worth over $49.8 billion and making up 65.1% of the portfolio value.
In addition, the fund holds 912,000 shares of Cargo Therapeutics Inc worth $15 billion.
The third-largest holding is Alumis Inc worth $10.5 billion and the next is Castle Biosciences worth $800 million, with 36,747 shares owned.
Currently, Yu Fan's portfolio is worth at least $76.5 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Yu Fan office and employees reside in Hong Kong, Hong Kong. According to the last 13-F report filed with the SEC, Fan Yu serves as the Self at Yu Fan.
In the most recent 13F filing, Yu Fan revealed that it had opened a new position in
Cg Oncology Inc and bought 1,578,344 shares worth $49.8 billion.
On the other hand, there are companies that Yu Fan is getting rid of from its portfolio.
Yu Fan closed its position in Prenetics Global Ltd on 14th August 2024.
It sold the previously owned 1,252,438 shares for $55 billion.
The two most similar investment funds to Yu Fan are Cognios Beta Neutral Large Cap Fund, L.P. and Clear Investment Research. They manage $76.7 billion and $76.3 billion respectively.
Yu Fan’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 1.0% of
the total portfolio value.
The fund focuses on investments in the United States as
16.7% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $655 million.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Prenetics Global Ltd |
Closed
1,252,438
|
$54,982,028,000 | |
| Cg Oncology Inc |
Opened
1,578,344
|
$49,828,320,000 | 65.11% |
| Castle Biosciences, Inc. |
Closed
737,000
|
$16,449,840,000 | |
| Cargo Therapeutics Inc |
Opened
912,000
|
$14,975,040,000 | 19.57% |
| Alumis Inc |
Opened
789,618
|
$10,501,919,000 | 13.72% |
| Castle Biosciences, Inc. |
Opened
36,747
|
$799,982,000 | 1.05% |
| Sonendo, Inc. |
Closed
22,503
|
$498,441,000 | |
| Pyxis Oncology Inc |
No change
69,303
|
$229,393,000 | 0.30% |
| Sagimet Biosciences Inc |
No change
57,190
|
$195,590,000 | 0.26% |
| No transactions found | |||
| Showing first 500 out of 9 holdings | |||